Journal of Commercial Biotechnology — February 2011 issue now available

The February 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 17, Issue 1

Editorial

Applying design thinking to biotechnologyPDF
Yali Friedman

Commentary

Building biotechnology by design: An entrepreneur’s perspectivePDF
Arthur A Boni
Building biotechnology by design: Role of biotechnology in developmentPDF
Patrick Nef

Articles

Pricing biologics: Issues, strategic priorities and a conceptual modelPDF
Sanjay K Rao
Revitalizing portfolio decision-making at Merck Serono S.A. – GenevaPDF
Vincent Aurentz, Bernhard Kirschbaum, Markus Thunecke
Global consensus – Need of the hour for genetically modified organisms (GMO) labelingPDF
Jagadeesan Premanandh
Beyond investment: Advancing the biotechnology sector in the countries of the Gulf Cooperation Council (GCC)PDF
Leonard Lerer, Brett Bowman

Case Study

Repurposing of the epidermal growth factorPDF
Ernesto L Mola, José A Buxadó, Luis Herrera
Biotechnology commercialization: A case study from Central and Eastern EuropePDF
Dana Ukropcova, Ernest Sturdik
The developments in the business models of biotechnology in the Central and Eastern European countries: The example of EstoniaPDF
Margit Suurna

Legal and Regulatory Updates

EU Legal and Regulatory UpdatePDF
Gerry Kamstra


Comments are closed.

Biotechblog